We are live on ! Find out more
Dmitry Balyasny

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B Turnover 42.78%
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$3.01B
Cap. Flow %
-3.76%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.95%
2 Technology 12.69%
3 Industrials 9.95%
4 Consumer Discretionary 8.03%
5 Healthcare 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LBRX icon
526
LB Pharmaceuticals
LBRX
$1.28B
$29.9M 0.04%
921,471
-2,223
-0.2% -$65.3K
2025 Q3
3 quarters
ROKU icon
527
CALL
Roku
ROKU
$23.3B
$29.8M 0.04%
215,800
+150,400
+230% +$18.3M
2024 Q1
9 quarters
VMRK icon
528
Vivmark Residential
VMRK
$48.4B
$29.8M 0.04%
438,236
+433,104
+8,439% +$28M
2025 Q4
2 quarters
OGN icon
529
Organon & Co
OGN
$3.61B
$29.7M 0.04%
2,196,642
+1,978,742
+908% +$23.7M
2026 Q1
1 quarter
LYV icon
530
Live Nation Entertainment
LYV
$40.1B
$29.6M 0.04%
161,795
-351,423
-68% -$57.8M
2025 Q2
4 quarters
HRL icon
531
Hormel Foods
HRL
$11.5B
$29.6M 0.04%
+1,193,319
New +$26.5M
2026 Q2
0 quarters
XLK icon
532
PUT
State Street Technology Select Sector SPDR ETF
XLK
$125B
$29.5M 0.04%
+155,000
New +$26.5M
2026 Q2
0 quarters
VRSK icon
533
Verisk Analytics
VRSK
$24.4B
$29.5M 0.04%
164,439
+89,160
+118% +$15.7M
2025 Q2
4 quarters
ONON icon
534
On Holding
ONON
$10.8B
$29.5M 0.04%
832,377
-1,044,862
-56% -$38.2M
2025 Q2
4 quarters
HUBB icon
535
Hubbell
HUBB
$22.9B
$29.4M 0.04%
56,271
-12,948
-19% -$6.54M
2023 Q3
11 quarters
UNP icon
536
PUT
Union Pacific
UNP
$178B
$29.4M 0.04%
108,000
+36,800
+52% +$9.7M
2022 Q1
17 quarters
COLB icon
537
Columbia Banking Systems
COLB
$8.78B
$29.3M 0.04%
913,570
-366,493
-29% -$10.9M
2025 Q1
5 quarters
STUB icon
538
StubHub Holdings
STUB
$2.12B
$29.1M 0.04%
+2,257,906
New +$19.9M
2026 Q2
0 quarters
CDNL icon
539
Cardinal Infrastructure Group
CDNL
$325M
$28.5M 0.04%
302,634
+192,841
+176% +$11.1M
2025 Q4
2 quarters
WBI icon
540
WaterBridge Infrastructure LLC
WBI
$1.66B
$28.5M 0.04%
831,453
+812,377
+4,259% +$23.6M
2025 Q3
3 quarters
JHG icon
541
DELISTED
Janus Henderson
JHG
$28.5M 0.04%
548,203
+2,128
+0.4% +$110K
2025 Q3
3 quarters
ARE icon
542
Alexandria Real Estate Equities
ARE
$7.03B
$28.3M 0.04%
+536,294
New +$25.7M
2026 Q2
0 quarters
XLV icon
543
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$47.1B
$28.1M 0.04%
176,900
+23,500
+15% +$3.5M
2023 Q2
12 quarters
SGMT icon
544
Sagimet Biosciences
SGMT
$739M
$28M 0.03%
+3,626,113
New +$24.7M
2026 Q2
0 quarters
CRC icon
545
California Resources
CRC
$4.81B
$28M 0.03%
529,735
+229,459
+76% +$14.1M
2023 Q4
10 quarters
SAIA icon
546
Saia
SAIA
$9.07B
$28M 0.03%
66,470
-44,387
-40% -$19.5M
2023 Q2
12 quarters
BHVN icon
547
Biohaven
BHVN
$2.31B
$28M 0.03%
1,879,734
-565,682
-23% -$6.09M
2025 Q3
3 quarters
BKR icon
548
Baker Hughes
BKR
$58.6B
$27.9M 0.03%
503,321
-1,758,738
-78% -$111M
2023 Q1
13 quarters
PG icon
549
CALL
Procter & Gamble
PG
$369B
$27.9M 0.03%
190,400
+165,600
+668% +$24.1M
2022 Q4
14 quarters
BA icon
550
CALL
Boeing
BA
$133B
$27.8M 0.03%
128,200
+99,200
+342% +$22.1M
2022 Q1
17 quarters

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.